Drainage surgery going down; cataract surgery going up

Article

The use of glaucoma drainage surgery is decreasing in Britain, which may be explained by an increase in cataract extraction, according to a report published in the January issue of Eye.

The use of glaucoma drainage surgery is decreasing in Britain, which may be explained by an increase in cataract extraction, according to a report published in the January issue of Eye.

Scott Fraser from the Sunderland Eye Infirmary, Tyne and Wear and Richard Wormald from Moorfields Eye Hospital and the London School of Hygiene and Tropical Medicine, London, UK used National Health Service (NHS) Hospital Episode Statistics (HES) to investigate a reported decrease in the rate of glaucoma surgery and whether this may be linked to increased medical therapy options.

The HES was accessed for the main glaucoma procedures between 1998 and 2004 and for cataract operations performed over the same period. Diagnostic data was extracted for glaucoma and figures for the changes in glaucoma medications were obtained from pharmaceutical data.

Over the investigated time period, trabeculectomy had reduced by 51%, laser trabeculoplasty by 60% and laser peripheral iridectomy by 30%. Cataract extractions had increased by 52% and medical treatments, such as prostaglandin use, had also increased. The number of admissions for acute glaucoma did not increase.

The results of this review, as with previous studies, demonstrate that glaucoma drainage surgery is decreasing and that cataract extraction is increasing. However, it also revealed that there was no increase in the diagnosis of angle closure glaucoma, which the researchers think may be related to the increase in cataract extractions.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.